Effectiveness of a Digital Health Application for Primary Hypertension (Liebria): Randomized Controlled Trial
This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
• Age ≥ 18
• Presence of primary hypertension, confirmed by submission of a medical certificate or equivalent (e.g., informal letter signed by primary care physician); relevant ICD-10-GM diagnoses:
‣ I10.00 (Benign essential hypertension: Without indication of hypertensive crisis)
⁃ I10.90 (Essential hypertension, unspecified: Without indication of hypertensive crisis)
• Unmedicated or with existing antihypertensive drug therapy (with stable dose in the past 6 weeks prior to study enrolment)
• Last reported office-based systolic blood pressure (SBP) ≥ 140 mmHg followed by home-based SBP ≥ 135 mmHg
• Consent to participate